Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-9

Theranostic performance of EGFR-targeted ceria-based nanoparticles on EGFR-positive cancers

Kochurani K Johnson, Pramod Koshy, Chantal Kopecky [...]

Journal of Biomaterials Applications

Retricted access

Review article

First published 2012-6

EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC

Kimberly J Gorden, Parvin Mesbah, Jill M Kolesar

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

Optimizing Patient Outcomes Through Sequential EGFR TKI Treatment in Asian Patients With EGFR Mutation-Positive NSCLC

Rong Liu, Jianying Zhou, Xia Ling

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2020-9

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

R Donald Harvey, Val R Adams, Tyler Beardslee [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2022-12

Observation on the clinical efficacy and side effects of EGFR-TKI ± chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma

Jianping Zheng, Tongjian Cui, Ting Li

European Journal of Inflammation

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2010-09

The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations

Isamu Okamoto, Tetsuya Mitsudomi, Kazuhiko Nakagawa [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-7

Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

Vera Jokic, Katarina Savic-Vujovic, Jelena Spasic [...]

Dose-Response

Open access

Research article

First published 2024

Efficacy and Safety of Anlotinib in EGFR-Positive Patients with Advanced Lung Adenocarcinoma Compared with Chemotherapy: A Retrospective Study

Cuihong Cai, Qian Shen, Jingjing Shao [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2018

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Po-Lan Su, Yi-Lin Wu, Wei-Yuan Chang [...]

Therapeutic Advances in Medical Oncology

Search results